Harvest Management’s Inozyme Pharma INZY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-50,000
Closed -$200K 85
2025
Q2
$200K Buy
+50,000
New +$124K 0.09% 55

Harvest Management's INZY Position: Q3 2025 in Review

Harvest Management sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 50,000 shares — an estimated $200K sold.

Harvest Management first reported a position in INZY in Q2 2025 and held it in 1 quarter. The position peaked at $200K in Q2 2025. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

  • Harvest Management reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
  • Harvest Management sold 50,000 Inozyme Pharma shares in Q3 2025, an estimated $200K.
  • Harvest Management first reported a position in Inozyme Pharma in Q2 2025 and held it in 1 quarter.
  • Harvest Management's Inozyme Pharma position peaked at $200K in Q2 2025.
  • 0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on Harvest Management's 13F filing for Q3 2025, filed 14 Nov 2025.